Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
NCT00237159
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
284
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer Patients With Bone Metastasis
Interventions
DRUG:
Zoledronic acid
Sponsor
Novartis Pharmaceuticals